• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4597351)   Today's Articles (5551)   Subscriber (49349)
Number Citation Analysis
51
Georgieva R. [Application of activated recombinant factor VII (rFVIIa, NovoSeven) in neonatology]. AKUSHERSTVO I GINEKOLOGIIA 2008;47:46-50. [PMID: 18756832] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
52
Saeed G, Ganster G, Friedel N. Was systemic venous thrombosis really due to the administration of recombinant factor VIIa? or was it possibly a manifestation of Lemierre syndrome? Tex Heart Inst J 2008;35:373-376. [PMID: 18941643 PMCID: PMC2565521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
53
Controlled off-label use of recombinant activated factor VII (NovoSeven) can build evidence base. Cardiovasc J Afr 2008;19:52-54. [PMID: 18320092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]  Open
54
Hammer GB, Williams GD. Use of recombinant activated factor VII in children. Paediatr Anaesth 2007;17:1123-5. [PMID: 17986029 DOI: 10.1111/j.1460-9592.2007.02344.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
55
Van de Velde M. Recombinant factor VIIa should be used in massive obstetric haemorrhage. Int J Obstet Anesth 2007;16:357-9. [PMID: 17702565 DOI: 10.1016/j.ijoa.2007.06.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/01/2007] [Indexed: 11/18/2022]
56
Mannucci PM. Intracerebral haemorrhage and recombinant factor VIIa: not so good news! Intern Emerg Med 2007;2:235-6. [PMID: 17912491 DOI: 10.1007/s11739-007-0067-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/11/2007] [Accepted: 05/14/2007] [Indexed: 12/01/2022]
57
Plaat F. Recombinant factor VIIa should be used in massive obstetric haemorrhage. Int J Obstet Anesth 2007;16:354-7. [PMID: 17698342 DOI: 10.1016/j.ijoa.2007.06.001] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2007] [Indexed: 11/17/2022]
58
Konkle BA, Ebbesen LS, Erhardtsen E, Bianco RP, Lissitchkov T, Rusen L, Serban MA. Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. J Thromb Haemost 2007;5:1904-13. [PMID: 17723130 DOI: 10.1111/j.1538-7836.2007.02663.x] [Citation(s) in RCA: 256] [Impact Index Per Article: 15.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
59
Quintana Díaz M, Sánchez Casado M, García de Lorenzo y Mateos A. Factor VII activado recombinante. Med Intensiva 2007;31:326-30. [PMID: 17663958 DOI: 10.1016/s0210-5691(07)74831-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
60
Johnson SJ, Ross MB, Moores KG. Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery. Am J Health Syst Pharm 2007;64:1808-12. [PMID: 17724361 DOI: 10.2146/ajhp060398] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]  Open
61
Cameron P, Phillips L, Balogh Z, Joseph A, Pearce A, Parr M, Jankelowitz G. The use of recombinant activated factor VII in trauma patients: Experience from the Australian and New Zealand haemostasis registry. Injury 2007;38:1030-8. [PMID: 17706654 DOI: 10.1016/j.injury.2007.05.003] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/09/2007] [Revised: 05/08/2007] [Accepted: 05/09/2007] [Indexed: 02/02/2023]
62
Tritapepe L, De Santis V, Vitale D, Nencini C, Pellegrini F, Landoni G, Toscano F, Miraldi F, Pietropaoli P. Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: A propensity score analysis*. Crit Care Med 2007;35:1685-90. [PMID: 17522585 DOI: 10.1097/01.ccm.0000269033.89428.b3] [Citation(s) in RCA: 44] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
63
Silver DA, D'Ambra MN. Recombinant activated factor VII in cardiac surgery—Will we ever know for sure?*. Crit Care Med 2007;35:1782-3. [PMID: 17581365 DOI: 10.1097/01.ccm.0000269395.46821.ef] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
64
Stanworth SJ, Birchall J, Doree CJ, Hyde C. Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia. Cochrane Database Syst Rev 2007:CD005011. [PMID: 17443565 DOI: 10.1002/14651858.cd005011.pub2] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
65
Thomas GOR, Dutton RP, Hemlock B, Stein DM, Hyder M, Shere-Wolfe R, Hess JR, Scalea TM. Thromboembolic Complications Associated With Factor VIIa Administration. ACTA ACUST UNITED AC 2007;62:564-9. [PMID: 17414329 DOI: 10.1097/ta.0b013e318031afc2] [Citation(s) in RCA: 71] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
66
Charbonneau S, Girard F, Boudreault D, Ruel M, Blais N, Hardy JF. Recombinant human activated factor VII is thrombogenic in a rabbit model of cyclic flow reduction and does not reduce intra-abdominal bleeding. Thromb Haemost 2007;97:296-303. [PMID: 17264960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/13/2023]
67
Mahmoud A, Al-Ruzzeh S, McKeague H, Cross M. Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery. Tex Heart Inst J 2007;34:485-488. [PMID: 18172537 PMCID: PMC2170501] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
68
Lyseng-Williamson KA, Plosker GL. Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX. PHARMACOECONOMICS 2007;25:1007-1029. [PMID: 18047387 DOI: 10.2165/00019053-200725120-00004] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
69
Al-Ruzzeh S, Mahmoud A, Shah S, O'Regan D. Caution With the Use of Recombinant Activated Factor VII in Treating Postoperative Hemorrhage in Cardiac Surgery. Ann Thorac Surg 2007;83:355; author reply 355-6. [PMID: 17184710 DOI: 10.1016/j.athoracsur.2006.06.076] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/08/2006] [Revised: 05/08/2006] [Accepted: 06/27/2006] [Indexed: 11/28/2022]
70
Dutton RP, Stein DM. The use of factor VIIa in haemorrhagic shock and intracerebral bleeding. Injury 2006;37:1172-7. [PMID: 17087958 DOI: 10.1016/j.injury.2006.09.001] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
71
Alexander E. Emerging Role of Recombinant Factor VIIa in Neuroscience. AACN Adv Crit Care 2006;17:363-7. [PMID: 17091036 DOI: 10.4037/15597768-2006-4001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
72
Special report: recombinant activated factor VII for uncontrolled bleeding in non-hemophiliac patients. TECHNOLOGY EVALUATION CENTER ASSESSMENT PROGRAM. EXECUTIVE SUMMARY 2006;21:1-2. [PMID: 17061400] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/12/2023]
73
Chin C. Recombinant activated factor VII. Paediatr Anaesth 2006;16:907-9. [PMID: 16918650 DOI: 10.1111/j.1460-9592.2006.02034.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
74
von Depka M, Hassan M, Blatnŷ J, Smejkal P, Vdovin V. The use of recombinant–activated factor VII in von Willebrand disease: a case series. Blood Coagul Fibrinolysis 2006;17:311-6. [PMID: 16651875 DOI: 10.1097/01.mbc.0000224852.42625.0d] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
75
Brandsborg S, Sørensen B, Poulsen LH, Ingerslev J. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients. Blood Coagul Fibrinolysis 2006;17:241-9. [PMID: 16651865 DOI: 10.1097/01.mbc.0000224842.25592.8a] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
PrevPage 3 of 6 123456Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA